MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-28-2026
Ekso Bionics Holdings Total Assets 2011-2026 | EKSO
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Ekso Bionics Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.1 M | 26.7 M | 28.9 M | 40.9 M | 49.2 M | 20.6 M | 21.9 M | 17.7 M | 38 M | 24.4 M | 32.2 M | 33.5 M | 29.2 K | 8.44 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 49.2 M | 8.44 K | 25.3 M |
Quarterly Total Assets Ekso Bionics Holdings
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.7 M | 20.1 M | 23.2 M | 27.3 M | 26.7 M | 29.2 M | 27 M | 29 M | 28.9 M | 31.2 M | 34 M | 37.1 M | 40.9 M | 39.3 M | - | 44.2 M | 49.2 M | 50.7 M | 53 M | 56.5 M | 20.6 M | 20.6 M | 20.6 M | 20.6 M | 21.9 M | 21.9 M | 21.9 M | 21.9 M | 17.7 M | 17.7 M | 17.7 M | 17.7 M | 38 M | 38 M | 38 M | 38 M | 24.4 M | 24.4 M | 24.4 M | 24.4 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 33.5 M | 33.5 M | 33.5 M | 33.5 M | 6.58 M | 6.58 M | 6.58 M | 6.58 M | 30 K | 12.7 K | 5.23 K | 8.44 K | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 56.5 M | 5.23 K | 26.3 M |
Total Assets of other stocks in the Medical instruments industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
261 K | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
12.4 B | $ 68.62 | 2.74 % | $ 13.7 B | USA |
 |
Glaukos Corporation
GKOS
|
893 M | $ 126.34 | 3.59 % | $ 7.23 B | USA |
 |
Luminex Corporation
LMNX
|
825 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
10.9 M | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
20.5 B | $ 426.61 | 1.91 % | $ 152 B | USA |
 |
Alcon
ALC
|
31.6 B | $ 67.9 | 2.71 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
4.05 B | $ 142.0 | 3.29 % | $ 3.5 B | USA |
 |
iRhythm Technologies
IRTC
|
1.02 B | $ 113.83 | 6.15 % | $ 3.64 B | USA |
 |
Repro Med Systems
KRMD
|
28.2 M | $ 4.0 | 0.25 % | $ 185 M | USA |
 |
LeMaitre Vascular
LMAT
|
616 M | $ 96.59 | 1.56 % | $ 2.19 B | USA |
 |
Masimo Corporation
MASI
|
2.63 B | $ 179.95 | 0.01 % | $ 9.59 B | USA |
 |
Microbot Medical
MBOT
|
81.5 M | $ 1.82 | - | $ 83.3 M |  Israel |
 |
Antares Pharma, Inc.
ATRS
|
213 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.07 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
192 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
4.67 B | - | -0.05 % | $ 10.3 B | USA |
 |
Milestone Scientific
MLSS
|
7.81 M | $ 0.39 | 0.29 % | $ 32 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
4.46 B | - | -0.02 % | $ 16.3 B | USA |
 |
Merit Medical Systems
MMSI
|
2.69 B | $ 67.51 | 2.24 % | $ 3.99 B | USA |
 |
electroCore
ECOR
|
18.7 M | $ 9.52 | -1.24 % | $ 80.8 K | USA |
 |
Envista Holdings Corporation
NVST
|
5.68 B | $ 24.59 | 4.91 % | $ 4.13 B | USA |
 |
Haemonetics Corporation
HAE
|
2.4 B | $ 78.71 | 5.11 % | $ 3.71 B | USA |
 |
STERIS plc
STE
|
10.7 B | $ 212.88 | 1.1 % | $ 20.9 B | USA |
 |
Isoray
ISR
|
267 M | - | 0.03 % | $ 108 M | USA |
 |
STAAR Surgical Company
STAA
|
452 M | $ 29.87 | -0.3 % | $ 1.48 B | USA |
 |
InfuSystem Holdings
INFU
|
101 M | $ 9.01 | - | $ 186 M | USA |
 |
Teleflex Incorporated
TFX
|
6.95 B | $ 135.75 | 3.04 % | $ 6.06 B | USA |
 |
Utah Medical Products
UTMD
|
123 M | $ 68.07 | 1.52 % | $ 221 M | USA |
 |
West Pharmaceutical Services
WST
|
4.27 B | $ 334.66 | 4.66 % | $ 24.2 B | USA |
 |
Pulse Biosciences
PLSE
|
94.5 M | $ 25.77 | 3.74 % | $ 1.74 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
5.43 B | $ 10.47 | 2.05 % | $ 2.09 B | USA |
 |
Retractable Technologies
RVP
|
143 M | $ 0.69 | 0.16 % | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
61.2 M | $ 65.0 | - | $ 214 M | USA |
 |
Predictive Oncology
POAI
|
52.9 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
406 M | $ 27.55 | 5.56 % | $ 1.32 B | USA |
 |
Stereotaxis
STXS
|
52.3 M | $ 1.85 | 2.21 % | $ 168 M | USA |
 |
Baxter International
BAX
|
20.1 B | $ 20.03 | 4.16 % | $ 10.3 B | USA |
 |
ResMed
RMD
|
5.1 B | $ 196.94 | 1.97 % | $ 28.8 B | USA |
 |
AtriCure
ATRC
|
654 M | $ 27.3 | 1.43 % | $ 1.3 B | USA |
 |
Harvard Bioscience
HBIO
|
80.1 M | $ 6.04 | 0.5 % | $ 268 M | USA |
 |
NeuroMetrix
NURO
|
15.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
280 M | $ 12.34 | 3.44 % | $ 504 M | USA |
 |
Becton, Dickinson and Company
BDX
|
55.3 B | $ 152.04 | 2.08 % | $ 43.7 B | USA |
 |
Nephros
NEPH
|
13.6 M | $ 3.25 | -4.13 % | $ 34.5 M | USA |
 |
OraSure Technologies
OSUR
|
403 M | $ 4.24 | 2.17 % | $ 312 M | USA |
 |
Repligen Corporation
RGEN
|
2.95 B | $ 130.13 | 3.83 % | $ 7.32 M | USA |